What is Risperdal?
Also known by the generic name risperidone, Risperdal is a powerful, anti-psychotic medication prescribed to treat schizophrenia, autism and bipolar disorders. It was first approved by the U.S. Food and Drug Administration (FDA) in 1994 for the treatment of schizophrenia in adults. In 2006, Risperdal was approved for use in children and adolescents experiencing irritability from autism. In 2007, the drug was approved to treat schizophrenia in ages 13 to 17 and bipolar disorder in ages 10 to 17. Risperdal is accompanied by an extensive list of side effects.
Off-Label Uses of Risperdal for Children
Risperdal was allegedly marketed before it was approved for adolescent use by the FDA. The drug was promoted to treat the following childhood disorders.
- Attention deficit hyperactivity disorder
- Oppositional defiant disorder
- Obsessive-compulsive disorder
“J&J’s promotion of Risperdal for unapproved uses threatened the most vulnerable populations of our society – children, the elderly and those with developmental disabilities,” said U.S. Attorney for the Eastern District of Pennsylvania Zane Memeger, regarding the recent government settlement agreement. “This historic settlement sends the message that drug manufacturers who place profits over patient care will face severe criminal and civil penalties.”
Contact the pharmaceutical attorneys at Simmons Hanly Conroy for more information about filing a Risperdal lawsuit.
I am very pleased and had a wonderful experience with the firm. Would definitely use their services again.